Journal of Clinical Oncology · 1998 · 217 citations · 45 references
MedicineNuclear MedicineRadiologyCost-effectiveness AnalysisDiagnostic ImagingDiagnostic RadiologyCost-effectiveness ComparisonCost-effectiveness ModelingHealthcare Cost AnalysisIncremental Cost-effectiveness AnalysisPulmonary ImagingPulmonary Nuclear ImagingComparative Cost-effectivenessCost Savings AnalysisCost-effectivenessCost-effectiveness Of Diagnostic TestingPositron Emission Tomography DetectionPositron Emission Tomography DiagnosisPretest Risk EstimationSolitary Pulmonary Nodule Assessment
PURPOSE AND METHODS: Multiple strategies are currently being used to manage patients who present with indeterminate solitary pulmonary nodules (SPN). We have used decision-analysis models to assess the cost-effectiveness of various strategies for the diagnosis and management of SPN. Four decision strategies were compared: a wait and watch strategy, a surgery strategy, a computed tomography (CT)-based strategy, and a CT-plus-positron emission tomography (PET) strategy. An incremental cost-effectiveness ratio (ICER) was used to compare all strategies to the wait and watch strategy. RESULTS: A CT-plus-PET strategy was the most cost-effective over a large pretest likelihood (probability of having a malignant nodule), with a range of 0.12 to 0.69. Furthermore, within this likelihood range, the potential cost savings of using the CT-plus-PET strategy over the CT strategy ranged from $91 to $2,200 per patient. This translates to a yearly national savings of approximately $62.7 million. CONCLUSION: Decision-analysis modeling indicates the potential cost-effectiveness of [18F]2-fluoro-2-deoxy-D-glucose (FDG)-PET in the management of SPN. Furthermore, the decision trees developed can be used to model various features of the management of SPN, including modeling the cost-effectiveness of other newly emerging technologies.
45
Otto Warbürg · Science · 1956 · 13.3K citations
Solitary pulmonary nodule: high-resolution CT and radiologic-pathologic correlation.
Charles Zwirewich, Sverre Vedal, Roberta R. Miller et al. · Radiology · 1991 · 532 citations
Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.
Edward F. Patz, Val J. Lowe, John M. Hoffman et al. · Radiology · 1993 · 512 citations
A FLUORINATED GLUCOSE ANALOG, 2-FLUORO-2-DEOXY-D-GLUCOSE (F-18)
P. Som, Harold Atkins, D. Bandoypadhyay et al. · Journal of Computer Assisted Tomography · 1980 · 503 citations
A convenient approximation of life expectancy (the “DEALE”)
J. Robert Beck, Stephen G. Pauker, Jonathan E. Gottlieb et al. · The American Journal of Medicine · 1982 · 478 citations